logo-loader

Insight Widest with the analysis. We look at the companies others don’t, giving access to the opportunities others won’t.

Matinas BioPharma advances the promise of heart-healthy omega-3...

The New Jersey-based company's lead product candidate, MAT9001 is for the treatment of cardiovascular and...

Opinion We bridge the gap between knowledge and ignorance and give you the angle that hard facts alone won’t

Research Independent research from the expert Proactive analyst team

Computacenter PLC - UK tech stocks pull back with US tech sell-off

Strategic Minerals

UK tech stocks pull back with US tech sell-off

Health

MaxCyte: Expanded...

MaxCyte has confirmed that its CARMA Cell Therapies subsidiary will expand its phase I...

Health

Are small-cap biotech...

We look at the sector's success stories and assess what we can expect in the coming...

Health

Open Orphan: World-leading...

Open Orphan (LON:ORPH) has rapidly restructured and integrated its Venn and hVIVO...